BSX · News · 20260810N

Capital Return Program

BOSTON SCIENTIFIC CORP · 2026-08-10 · Importance 64 · Surprise 42

Boston Scientific authorized a $5 billion share-repurchase program following its second-quarter 2026 results. The authorization was cited alongside quarterly revenue of $5.44 billion and adjusted EPS of $0.86. The digest does not specify the program’s expiration date, execution timing, or repurchase amount completed to date.

Key facts

• BOSTON SCIENTIFIC CORP director Habiger acquired 2,100 shares for approximately $100,000 on August 5, 2026, representing a 14% increase in total direct equity holdings. source
• BOSTON SCIENTIFIC CORP CEO Michael F. Mahoney purchased over 200,000 shares for more than $10 million. source